Dokla, Eman
emanelawady@pharma.asu.edu.eg
Department of Pharmaceutical Chemistry - Pharmacy
Interests: Rational design and computational modeling of small molecules targeting cancer‑related pathways, including kinase inhibitors, protein–protein interaction modulators, and epigenetic targets, Design, synthesis, and optimization of small‑molecule anticancer agents, with emphasis on dual‑target inhibitors and molecules modulating mitochondrial respiration and ER‑stress signaling, Development of novel antimicrobial agents and structural optimization toward lead identification and preclinical candidate advancement, Integration of structure‑based and ligand‑based drug design (docking, MD simulations, pharmacophore modeling, and virtual screening) to support discovery of bioactive small molecules across oncology and infectious disease indications,
Internal ID: rp11910
- 221 Scopus Citations
- 50 PubMed Citations
Loading...
2
0
20
0
false
Full Name
Dokla, Eman
Affiliation (Department)
Scopus Author ID
WOS ID
Biography
Eman M.E. Dokla is an associate professor at the department of Pharmaceutical Chemistry, Ain Shams University, Egypt. Her current research interest focuses on targeted cancer therapy and the development of novel antimicrobial agents. She has co-authored several peer-reviewed papers on the discovery and development of small-molecule kinase inhibitors targeting breast cancer and acute myeloid leukemia, and protein degraders targeting breast, lung, and oral squamous cell cancers. In this context, her work comprises drug discovery and medicinal chemistry efforts for small-molecule inhibitors’ development and optimization.
Results 21-23 of 23 (Search time: 0.0 seconds).